Compare · DHR vs MASS
DHR vs MASS
Side-by-side comparison of Danaher Corporation (DHR) and 908 Devices Inc. (MASS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and MASS operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $162.74B, about 331.1x MASS ($491.5M).
- DHR has been more active in the news (12 items in the past 4 weeks vs 5 for MASS).
- DHR has more recent analyst coverage (25 ratings vs 7 for MASS).
- Company
- Danaher Corporation
- 908 Devices Inc.
- Price
- -
- -
- Market cap
- $162.74B
- $491.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 12
- 5
- Recent ratings
- 25
- 7
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
908 Devices Inc.
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Latest DHR
- SEC Form 3 filed by Danaher Corporation
- SEC Form 3 filed by Danaher Corporation
- SEC Form 4 filed by Danaher Corporation
- SEC Form 4 filed by Danaher Corporation
- Danaher Collaborates with NVIDIA to Advance Autonomous Science
- SEC Form 8-K filed by Danaher Corporation
- Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors
- Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab
- New insider Moler Heathre T claimed ownership of 5,356 shares (SEC Form 3)
- New insider Muppaneni Shashanka claimed ownership of 5,901 shares (SEC Form 3)
Latest MASS
- SEC Form 4 filed by 908 Devices Inc.
- SEC Form 4 filed by 908 Devices Inc.
- SEC Form 144 filed by 908 Devices Inc.
- Large owner Awm Investment Company, Inc. sold $207,322 worth of shares (18,000 units at $11.52) (SEC Form 4)
- Large owner Awm Investment Company, Inc. sold $283,876 worth of shares (25,000 units at $11.36) (SEC Form 4)
- SVP, Sales & Product Marketing Kenneweg John sold $280,070 worth of shares (27,656 units at $10.13) as part of a pre-agreed trading plan and exercised 27,656 shares at a strike of $0.96 (SEC Form 4)
- Canaccord Genuity initiated coverage on 908 Devices with a new price target
- 908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
- Chief Financial Officer Griffith Joseph H. Iv sold $125,476 worth of shares (11,459 units at $10.95) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 121,497 units (SEC Form 4)
- SEC Form 144 filed by 908 Devices Inc.